Stay updated on Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.

Latest updates to the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a newer version of the ClinicalTrials.gov entry. This change appears to be a metadata update rather than a modification to the study details.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision label updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page lists Naples, Italy, 80131 instead of Napoli, Italy, 80131, and the revision tag changes from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check60 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check89 days agoChange DetectedAdded a new site revision label 'Revision: v3.4.2' and removed older revision notices 'v3.4.1' as well as a government funding status notice; these are routine site maintenance updates rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check96 days agoChange DetectedThe page now displays a government funding notice and shows the updated revision label (v3.4.1) while removing the previous label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.